Oncotarget: Pushing Researches by Spreading News on Cancer Treatments

Oncology is the branch of medicine that studies the diagnosis, prevention, and treatment of cancer, one of the most important and relevant fields today, because of the intense variety of types of cancer that exist and target people today.

Cancer is a cruel disease with many kinds and forms that can hit all of us, regardless of sex, age, social status, and even fitness status. Yes, to this day, it is still a mystery that some people who seem to be perfectly fit, have no vices and follow a strict pattern of healthy lifestyle, still get cancer. Listen to an audio podcast of Oncotarget on Itunes.

This reality, where Cancer is such an unpredictable disease with dozens of types, shapes, and forms, is precisely why the research on cancer and the understanding of it is fundamental to a higher quality of life, worldwide. And, of course, equally important is the research for its treatment and raising awareness about newly developed treatment to the people is very important.

Passionate Oncologists around the world are working double time on their studies and research about cancer and almost every week there are new developments. It is only right that the people become aware of these new developments, as they are constantly determining therapies and treatments for cancer with modern techniques.

Oncotarget is a journal available online that publishes two issues of bio-medical journals per week, that covers all kinds of research and all kinds of aspect concerning oncology. The subsections also feature topics that are beyond the topic of cancer, with studies on a molecular level, reflections about the process of aging, and other fields of medicine that are equally relevant today. Oncotarget can become your only source of free news from the medical world, and you will still be updated on thousands of topics from different pieces of the industry. Follow Oncotarget journal on Twitter.

It started publishing in 2010, and their editors, the responsible for the publications in the website, are two people who have left their marks in the world of oncology, Mikhail Blagosklonny and Andrei V. Gudkov.

The Journal highlights the works done by oncologists and the many newly discovered ways of treating cancer.

The editor is chief Mikhail Blagosklonny himself, who is known for his Rapamycin discovery which was extensively featured in Oncotarget. Rapamycin is now considered a wonder drug that helps in organ transplant and the prevention of the proliferation of cancer cells. Very recently, there was also a study published in Oncotarget that discusses the recently developed therapeutic strategies to treat thyroid cancer.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/

If you are interested in learning more about Oncology, take a look at this free website.

Leave a Reply